Olanzapine may increase the risk of death in older adults with psychosis (loss of touch with reality) related to dementia. Olanzapine is not approved for use in this group of people. For more ...

Please provide your email address to receive an email when new articles are posted on . Low-dose olanzapine appeared noninferior to standard dose for controlling chemotherapy-induced nausea and ...

Am J Health Syst Pharm. 2008;65(12):1180-1183. Ultimately, more formalized, high-quality, and clinically applicable studies are necessary to determine the safety of the parenteral combination of ...

Yoga-based supportive care for patients with head and neck cancer undergoing radiotherapy: Results of a three-arm randomized controlled trial. This is an ASCO Meeting Abstract from the 2023 ASCO ...

Schizophrenia and bipolar I disorder are two conditions that have many differences between them. A class of medicines called antipsychotics can be used to treat both conditions but may cause unwanted ...

Antiangiogenic tyrosine-kinase inhibitors (TKIs) play a key role in treating renal cell carcinoma and other solid organ malignancies, but TKIs cause bothersome side effects that frequently necessitate ...

Please provide your email address to receive an email when new articles are posted on . Patients assigned olanzapine achieved better nausea control than those assigned observation. More patients ...

Researchers from Japan found that a 5 mg dose of olanzapine, taken after chemotherapy, significantly reduces nausea and vomiting in breast cancer patients, while minimizing sedation and cutting costs.

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): TEV-‘749 / mdc-TJK - Investigational Olanzapine Long-Acting Injectable Teva presented positive data from the initial ...